Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio Key International (BKYI) Shares Issued (2017 - 2025)

Bio Key International's Shares Issued history spans 6 years, with the latest figure at $3.8 million for Q1 2025.

  • For Q1 2025, Shares Issued rose 272261.21% year-over-year to $3.8 million; the TTM value through Sep 2025 reached $3.7 million, down 40.9%, while the annual FY2024 figure was $1.9 million, 55.59% down from the prior year.
  • Shares Issued for Q1 2025 was $3.8 million at Bio Key International, up from -$91901.0 in the prior quarter.
  • Across five years, Shares Issued topped out at $4.3 million in Q4 2023 and bottomed at -$91901.0 in Q4 2024.
  • The 3-year median for Shares Issued is $2.0 million (2024), against an average of $2.0 million.
  • The largest annual shift saw Shares Issued plummeted 102.14% in 2024 before it skyrocketed 272261.21% in 2025.
  • A 3-year view of Shares Issued shows it stood at $4.3 million in 2023, then tumbled by 102.14% to -$91901.0 in 2024, then surged by 4249.09% to $3.8 million in 2025.
  • Per Business Quant, the three most recent readings for BKYI's Shares Issued are $3.8 million (Q1 2025), -$91901.0 (Q4 2024), and $2.0 million (Q3 2024).